News Imaging Biometrics Ltd.

Stocks

IBAI

JE00BD4H0R42

Healthcare Facilities & Services

Market Closed - London S.E. Other stock markets 11:35:26 2026-07-10 am EDT			5-day change	1st Jan Change
0.7000 ^GBX	0.00%		+11.11%	-17.65%

Jul. 06	WINNERS & LOSERS: Knights profit up; GoldStone raises GBP3.5 million	AN
Jun. 23	WINNERS & LOSERS: Ramsdens accepts GBP206 million Firstcash offer	AN

All News

Mentions Relevance

Jun. 09	Imaging Biometrics Limited Publishes Phase 1 Clinical Trial Results Of Oral Gallium Maltolate In Recurrent Glioblastoma And Reopens Expanded Access Programme	CI
Jun. 05	Imaging Biometrics eyes incremental revenue from IB Neuro technology	AN
Jun. 05	Imaging Biometrics Limited Presents EAF151 Phase II Results For IB Neuro Platform And Outlines Strategic Revenue Pathway	CI
Jun. 03	Imaging Biometrics Ltd. Announces the Release of Ib Nimble	CI
May. 12	Imaging Biometrics : 2026 AGM Notice	PU
May. 12	Imaging Biometrics : 2026 AGM Proxy	PU
May. 08	Imaging Biometrics Unit Selected as Industry Partner to Develop Living Glioblastoma Model	MT
Apr. 30	Imaging Biometrics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Feb. 19	Imaging Biometrics Limited Appoints John Charles Richardson as Non-Executive Director and Member of Remuneration and Audit Committees, Effective March 1, 2026	CI
Jan. 16	Imaging Biometrics scraps plans for phase 2 gallium maltolate trial	AN
Jan. 16	Imaging Biometrics to Drop Oral Gallium Maltolate Study	MT
Jan. 16	Img Biometrics Limited Provides an Update on Its Interest in the Development of Gallium Maltolate as Well as Its Strategic Priority for 2026	CI
Jan. 16	Imaging Biometrics directors decide against phase 2 trial of gallium maltolate	RE
Dec. 10	Imaging Biometrics Adds Two New Products to Distribution Deal With GE HealthCare	MT
Nov. 24	Imaging Biometrics Ltd. Announces Stepping Down of Al Musella from the Board of Directors, Effective December 31, 2025	CI
Nov. 13	Imaging Biometrics hails use of FTB solution in glioblastoma trial	AN
Nov. 13	Imaging Biometrics Ltd.'s Fractional Tumor Burden Mapping Enhances GBM Trial	CI
Nov. 10	Imaging Biometrics announces completion of phase 1 trial of GaM	RE
Nov. 10	Imaging Biometrics soars on results from glioblastoma treatment trial	AN
25-10-16	Truetide to Write Off Kirkstall Ltd's Loans Amid Sale to Imaging Biometrics	MT
25-10-14	Imaging Biometrics to Buy 86% Stake in Biotechnology Company Kirkstall	MT
25-10-13	Imaging Biometrics Ltd. acquired 86.11% stake in Kirkstall Limited from Truetide plc for £0.14 million.	CI
25-10-03	Vivan Therapeutics and Imaging Biometrics Announce Strategic Partnership to Advance Gallium Maltolate for New Cancer Indications	CI
25-10-03	Imaging Biometrics shares nearly double as inks partnership with Vivan	AN
25-09-17	Imaging Biometrics Partners with MedImageMetric for QSMetric Commercialization	MT